Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$593M |
| 2 |
Abbott
ABT
|
+$259M |
| 3 |
AutoZone
AZO
|
+$204M |
| 4 |
AABA
Altaba Inc
AABA
|
+$186M |
| 5 |
D.R. Horton
DHI
|
+$178M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Honeywell
HON
|
+$215M |
| 2 |
Public Service Enterprise Group
PEG
|
+$211M |
| 3 |
Applied Materials
AMAT
|
+$203M |
| 4 |
Intuitive Surgical
ISRG
|
+$194M |
| 5 |
ConocoPhillips
COP
|
+$192M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 14.49% |
| 2 | Technology | 12.13% |
| 3 | Healthcare | 11.89% |
| 4 | Consumer Discretionary | 11.58% |
| 5 | Industrials | 10.76% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
BIVV
851
DELISTED
Bioverativ Inc. Common Stock
BIVV
| $21.7M | 0.03% |
402,509
-62,921
| -14% | -$3.44M |
|
852
Starbucks
SBUX
$123B
| $21.7M | 0.03% |
377,846
+286,112
| +312% | +$16.2M |
|
853
CALL
AES
AES
$10.5B
| $21.7M | 0.03% |
+2,000,000
| New | +$21.6M |
|
854
Norwegian Cruise Line
NCLH
$7.91B
| $21.7M | 0.03% |
406,647
-765,996
| -65% | -$42.4M |
|
855
Rigel Pharmaceuticals
RIGL
$843M
| $21.6M | 0.03% |
557,433
+285,441
| +105% | +$10.9M |
|
|
FBR
856
DELISTED
Fibria Celulose Sa
FBR
| $21.6M | 0.03% |
1,469,006
-518,637
| -26% | -$7.88M |
|
857
American States Water
AWR
$3.61B
| $21.6M | 0.03% |
372,501
+323,080
| +654% | +$17.7M |
|
858
Modine Manufacturing
MOD
$10B
| $21.6M | 0.03% |
1,067,335
+478,987
| +81% | +$10.3M |
|
|
TMX
859
DELISTED
Terminix Global Holdings, Inc.
TMX
| $21.5M | 0.03% |
627,221
-18,657
| -3% | -$601K |
|
860
Asbury Automotive
ABG
$3.79B
| $21.5M | 0.03% |
336,039
+33,743
| +11% | +$2.11M |
|
861
Landstar System
LSTR
$6.11B
| $21.5M | 0.03% |
206,529
+80,344
| +64% | +$8.07M |
|
|
HDP
862
DELISTED
Hortonworks, Inc.
HDP
| $21.4M | 0.03% |
1,064,981
-311,496
| -23% | -$5.71M |
|
863
Yelp
YELP
$1.29B
| $21.4M | 0.03% |
510,262
+219,296
| +75% | +$9.75M |
|
864
Hilltop Holdings
HTH
$2.22B
| $21.4M | 0.03% |
843,779
+67,876
| +9% | +$1.66M |
|
|
PDM
865
Piedmont Realty Trust
PDM
$1.23B
| $21.3M | 0.03% |
1,087,136
-405,924
| -27% | -$8.09M |
|
|
LADR
866
Ladder Capital
LADR
$1.27B
| $21.3M | 0.03% |
+1,563,756
| New | +$21.4M |
|
867
Corcept Therapeutics
CORT
$13.3B
| $21.3M | 0.03% |
1,178,218
+331,287
| +39% | +$6M |
|
868
Ascendis Pharma A/S
ASND
$16.5B
| $21.3M | 0.03% |
530,791
+18,377
| +4% | +$668K |
|
869
Supernus Pharmaceuticals
SUPN
$2.62B
| $21.2M | 0.03% |
531,397
-3,112
| -0.6% | -$123K |
|
870
Eagle Materials
EXP
$6.27B
| $21.1M | 0.03% |
186,599
-162,559
| -47% | -$17.6M |
|
871
Minerals Technologies
MTX
$2.24B
| $21.1M | 0.03% |
306,732
+279,915
| +1,044% | +$19.9M |
|
872
ManpowerGroup
MAN
$2.86B
| $21.1M | 0.03% |
167,293
+163,227
| +4,014% | +$20.4M |
|
873
Lincoln Electric
LECO
$15.4B
| $21.1M | 0.03% |
230,281
+78,793
| +52% | +$7.2M |
|
|
ITCI
874
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $21.1M | 0.03% |
1,454,944
+71,980
| +5% | +$1.11M |
|
875
Nomad Foods
NOMD
$1.69B
| $21.1M | 0.03% |
1,245,188
-226,247
| -15% | -$3.52M |
|
Similar funds
Israel Englander's Q4 2017 Portfolio in Review
As of Q4 2017, Israel Englander held 4,357 positions worth $72.5B, up 10% from $65.6B the previous quarter. Its ten largest holdings account for 6.7% of the portfolio.
Israel Englander deployed $3.05B of net new capital in Q4 2017, opening 897 new positions and adding to 1,473 existing holdings. Its largest new stake was Viatris: 2,905,317 shares worth $123M.
By sector, the portfolio is most concentrated in Financials at 14% of assets, up from 14% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was Honeywell, an estimated $215M trimmed.
- Israel Englander's largest Q4 2017 buy was Viatris: 2,905,317 shares worth $123M.
- Israel Englander added most to State Street SPDR S&P 500 ETF Trust in Q4 2017, an estimated $593M increase.
- Israel Englander's biggest Q4 2017 reduction was Honeywell, cutting an estimated $215M.
- Israel Englander fully exited Paychex in Q4 2017, selling an estimated $66.4M.
- Israel Englander's ten largest holdings make up 6.7% of its $72.5B portfolio in Q4 2017.
- Israel Englander opened 897 new positions and closed 601 in Q4 2017.
- Israel Englander's portfolio value rose 10% quarter-over-quarter to $72.5B.
Based on Millennium Management's 13F filing for Q4 2017, filed 14 Feb 2018.